Star Combo Pharma Ltd.'s market cap is currently ―. The company's EPS TTM is AU$0.003; its P/E ratio is 41.67; Star Combo Pharma Ltd. is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19
Income Statement	-
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
EBIT	-	-	-	-
EBITDA	-	-	-	-
Net Income Common Stockholders	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 10.39M	AU$ 17.32M	AU$ 26.60M	AU$ 4.62M
Total Assets	AU$ 43.44M	AU$ 43.32M	AU$ 54.72M	AU$ 27.51M
Total Debt	AU$ 4.12M	AU$ 3.30M	AU$ 5.61M	AU$ 47.74K
Net Debt	AU$ -6.27M	AU$ -14.03M	AU$ -20.99M	AU$ -4.57M
Total Liabilities	AU$ 8.04M	AU$ 7.13M	AU$ 10.22M	AU$ 7.51M
Stockholders Equity	AU$ 35.41M	AU$ 36.19M	AU$ 44.50M	AU$ 20.00M
Cash Flow	-
Free Cash Flow	-	-	-	-
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	-	-

Currency in AUD

Star Combo Pharma Ltd. Earnings and Revenue History

Income Statement >

Star Combo Pharma Ltd. Debt to Assets

Balance Sheet >

Star Combo Pharma Ltd. Cash Flow

Cash Flow >

Star Combo Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing